Economic impact of the use of Hyalubrix® in the treatment of hip osteoarthritis in Italy
DOI:
https://doi.org/10.7175/fe.v15i4.977Keywords:
Hyaluronic acid, Coxarthrosis, Ultrasound-guided intra-articular injectionAbstract
The present study aims at evaluating the economic impact of the use of hyaluronic acid (Hyalubrix®60/HyalOne) as an alternative to surgery in the treatment of hip osteoarthritis, consistently with the therapeutic protocol envisaged in the Ortobrix study. To quantify the cost and efficacy of the treatment options under evaluation, the perspective of both the Italian NHS and the Society was considered. To this end, a decision analysis model was created over a 4-year period, to quantify the cost of treatments, procedures and adverse events, as well as the benefits expressed as survival rates and reduced lost workdays. The results show that, since the treatment with Hyalubrix® enables to avoid or delay the need for Total Hip Replacement (THR) surgery, it is possible to reduce mortality, adverse events and total costs. Hyalubrix®, given in the hip by ultrasound-guided intra-articular injection as an alternative to surgery is the most favourable option, helping preserve the survival rate over a 4-year period, of approximately 1 in 100 patients considered candidates for THR, preserve work capacity for a total differential amount of 500 days, and achieve considerable savings in economic terms, of approximately 550,000 € and 600,000€ euros from the NHS and the Societal perspectives, respectively.
References
Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute. La Bone and Joint Decade 2000-2010. Disponibile su: http://www.epicentro.iss.it/problemi/MuscoloScheletriche/BJD.asp (ultimo accesso settembre 2014)
World Health Organisation. The burden of musculoskeletal conditions at the start of the new millennium. WHO Technical Report Series 919, 2009
American College of Rheumatology (ACR) diagnostic Guideline. ACR Clinical classification criteria for Osteoarthritis of the hip, 2000. Disponibile su: http://www.hopkinsarthritis.org/ (ultimo accesso settembre 2014)
Istituto Nazionale di Statistica (ISTAT). Tutela della salute e accesso alle cure. 2014. Disponibile su: http://www.istat.it/it/archivio/128176 (ultimo accesso settembre 2014)
Punzi L, Doherty M, Zhang W, et al. Consensus italiana sulle raccomandazioni EULAR 2005 per il trattamento dell’artrosi dell’anca. Reumatismo 2006; 58: 301-9
Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken) 2012; 64: 465-74; http://dx.doi.org/10.1002/acr.21596
Agenzia Regionale di Sanità (ARS). ARS Toscana Rapporto 54/10 Implantologia Protesica dell’anca in Toscana, 2012. Disponibile su: www.ars.toscana.it (ultimo accesso settembre 2014)
Migliore A, Massafra U, Bizzi E, et al. Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix®) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther 2009; 11: R183; http://dx.doi.org/10.1186/ar2875
Migliore A, Massafra U, Bizzi E, et al. Intra-articular injection of hyaluronic acid (MW 1,500–2,000 kDa; HyalOne) in symptomatic osteoarthritis of the hip: a prospective cohort study. Arch Orthop Trauma Surg 2011; 131: 1677-85; http://dx.doi.org/10.1007/s00402-011-1353-y
Migliore A, Bella A, Bisignani M, et al. Total hip replacement rate in a cohort of patients affected by symptomatic hip osteoarthritis following intra-articular sodium hyaluronate (MW 1,500–2,000 kDa) ORTOBRIX study. Clin Rheumatol 2012; 31: 1187-96; http://dx.doi.org/10.1007/s10067-012-1994-4
Registro Regionale di Implantologia Protesica Ortopedica (RIPO). Dati complessivi Interventi di protesi d’anca, di ginocchio e di spalla in Emilia Romagna (2000-2011). Disponibile su: https://ripo.cineca.it/pdf/relazione_globale_2011.pdf (ultimo accesso settembre 2014)
Ministero della Salute. Remunerazione prestazioni di assistenza ospedaliera per acuti, assistenza ospedaliera di riabilitazione e di lungodegenza post acuzie e di assistenza specialistica ambulatoriale. Supplemento ordinario alla “Gazzetta Ufficiale, n. 23 del 28 gennaio 2013 - Serie generale
Ministero della Salute. Rapporto annuale sull’attività di ricovero ospedaliero. Dati SDO 2011 Ottobre 2012. Disponibile su: http://www.salute.gov.it/ (ultimo accesso settembre 2014)
Piscitelli P, Iolascon G, Di tanna G, et al. Socioeconomic Burden of Total Joint Arthroplasty for Symptomatic Hip and Knee Osteoarthritis in the Italian Population: A 5-Year Analysis Based on Hospitalization Records. Arthritis Care Res (Hoboken) 2012; 64: 1320-7; http://dx.doi.org/10.1002/acr.21706
Osservatorio Epidemiologico Regione Puglia (OERP). Registro di Implantologia Protesica Ortopedica Regione Puglia, 2011. Disponibile su: http://www.sanita.puglia.it/ (ultimo accesso settembre 2014)
Rapporto ISTAT 16 dicembre 2013. Reddito e condizioni di vita. Anno 2012
Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014; 73: 1323-30
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)
